Pemigatinib
About
Therapy type: Targeted therapy
Therapy strategy: FGFR inhibition
Mappings
NCI Thesaurus: Pemigatinib (ncit:C121553)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | FGFR2::v | Cholangiocarcinoma | Pemigatinib | |
| FDA (1) | FGFR2 rearrangements | Cholangiocarcinoma | Pemigatinib | |
| FDA (1) | FGFR1 rearrangements | Myeloid/Lymphoid Neoplasms | Pemigatinib |